StockTipsArenaBeta

SELL Divi's Laboratories Limited — Kotak Securities

SELLDivi's Laboratories Limited
Divi's Laboratories share price target & all analyst calls

byKotak SecuritiesHorizon: NA (inferred 1 year)26 Oct 2026via Financial Express Market

Entry₹9,050Inferred
Target₹7,560
Total upside +16.46%
Stop lossNot given
CMP₹9,558.510h ago
Active-5.62%+20.91%upside left 12 mo left
Follow Kotak Securities for new calls(89% target hit, 19 closed calls)Get alertsWatch DIVISLAB for new buy/sell callsGet alertsSee 7 other Long-term calls on DIVISLABSee 200 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.

As of 29 Oct, 2:48 am IST
2 supporting7 neutral9 opposing
Supports the SELL call (2)

2 other SEBI-registered advisors have active long-term SELL calls on this stock

Advisor consensus · same horizon·3 Aug · 3mo ago

Neutral / worth noting (7)

Q2 FY27 results scheduled — board meets 07 Nov 2026

BSE · Board Meeting·In 9 days

(opens in new tab)

Divi's Labs, TVS Motor could replace Max Healthcare, HDFC Life in NSE's March 2027 index review

NewsEt-Markets·6 Oct · 3w ago

(opens in new tab)
Weighs against the SELL call (9)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·28 Oct · today

Divi's Laboratories shares in focus as weight loss drug receives EU panel backing

NewsCnbc-Tv18·19 Oct · 1w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·26 Aug · 2mo ago

3 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·4 Aug · 3mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Divi's Laboratories

All analyst calls on Divi's Laboratories

More from Kotak Securities

Every call and its outcome